Veeva to deliver the only clinical suite that unifies CTMS and eTMF for one process, one system, and one view across clinical trials in the cloud
PLEASANTON, CA – Veeva Systems today introduced Veeva Vault CTMS, the industry’s first multitenant cloud application that unifies information, documentation, and processes globally for a single source of truth across clinical operations. Together with Veeva Vault eTMF, Veeva will offer the first and only suite of clinical applications that combines CTMS and eTMF on one cloud platform. Now, life sciences companies can accelerate trial execution and gain real-time visibility into their clinical operations. “The clinical development process is highly inefficient due to a number of factors, including the inconsistent use of a large number of disparate and incompatible technologies,” said Ken Getz, associate professor at Tufts University School of Medicine and chairman of the Center for Information and Study on Clinical Research Participation. “Transparency, compatibility, and integration are critical factors driving technology adoption among clinical research professionals, patients, and the broader health care environment.” The fragmented landscape in clinical operations stems from duplicate content and data in multiple systems across many processes in a growing, complex global ecosystem of stakeholders. System and process silos create challenges for operations leaders to plan and make informed decisions during clinical trials. “Veeva is bringing the next generation of clinical trial management to life sciences,” said Jennifer Goldsmith, senior vice president of Veeva Vault. “We are filling a significant gap in the industry with a unified suite of applications to provide one process, one system, and one view within and across clinical trials. For the first time, life sciences companies will be able to get full visibility into their clinical operations.” Veeva Vault CTMS will help life sciences companies unify their clinical trial operations to reduce complexity, increase transparency, and speed time-to-market by providing:
In a recent survey of eTMF owners, 49% cited integration between their eTMF and CTMS applications as a key need. Veeva Vault CTMS joins Vault eTMF and Veeva Vault Study Startup as part of the Vault Clinical Suite designed to unify clinical operations. Vault CTMS is the latest application built on Veeva Vault, a cloud platform and suite of applications specifically built for life sciences. Traditionally, companies deploy multiple applications to manage content and the associated data. Veeva Vault is the only content management platform with the unique capability to manage both content and data. Now life sciences companies can eliminate system, site, and country silos and streamline their end-to-end clinical processes. Vault CTMS is expected to be available in the first quarter of 2017.
Additional Information
For more on Veeva Vault CTMS:
veeva.com/VaultCTMS
For more on Veeva Vault Clinical Suite:
veeva.com/VaultClinical
Stay updated on the latest Veeva news on LinkedIn:
linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter:
twitter.com/veevasystems
Like Veeva on Facebook:
facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 400 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit
veeva.com
.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Making the Grade: Registries as Sources of Regulatory-Grade Real-World Evidence (RWE)
February 13th 2025Dr. Peter Wahl, MLA, MS, ScD, VP and Global Head of Scientific Affairs at CorEvitas, part of the PPD™ clinical research business of Thermo Fisher Scientific, discusses the critical role of protocol-driven registries in generating regulatory grade RWE to serve multiple and evolving evidence needs across the drug development life cycle. He covers key considerations for selecting the right type of registry, the advantages over EMR datasets, and how registry data contextualizes safety and effectiveness to fulfill FDA and EMA post-marketing requirements.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.